We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This review examines trials evaluating the effects of artemisinin-naphthoquine compared to other artemisinin-based combination therapies
You must tell DVLA if you have muscular dystrophy - download the correct form to let them know.
As with all medicines, the MHRA will keep the safety and effectiveness of Nipolcalimab under close review.
Volume 19 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Steps to help grow your business - finding finance, mentors, increasing sales and developing products and services
As with any medicinal product, the MHRA will keep the safety and effectiveness of the intravesical delivery system containing gemcitabine under close review.
How to employ an apprentice, what's expected of you and what funding you can get.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).